Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of ...

Christopher Nolan's Oppenheimer returned to theaters and is set to overtake Zack Snyder's Batman v. Superman as it climbs toward $1 billion.

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...

New York Athletic Commission issues statement regarding controversial call in Tank Davis vs. Lamont Roach fight ...

Oppenheimer Asset Management Inc. decreased its position in Affirm Holdings, Inc. (NASDAQ:AFRM – Free Report) by 22.8% in the ...

If you missed Oppenheimer in IMAX you can get another chance to see it this weekend with a one-week USA and Canada rerelease ...

The ending of Apple TV+ thriller Prime Target explained, including if Leo Woodall’s brilliant mathematician survives his ordeal.

Oppenheimer has downgraded LeMaitre Vascular (NASDAQ:LMAT) to perform from outperform as its price target of $93 has been met ...

David Krumholtz unfortunately developed a rare and extremely dangerous disease, and he feels the need to publicly alert ...

Oppenheimer analyst Jay Olson lowered the firm’s price target on Denali Therapeutics (DNLI) to $42 from $50 and keeps an Outperform rating on the shares following quarterly results and after hosting ...

The audience for the highest honors in Hollywood fell 7% from the 2024 ceremony, when 19.5 million people tuned in to see ...